WHO Strategic Advisory Boka reNyanzvi (SAGE)on Immunization yakapa kurudziro yenguva pfupi yekushandiswa kweiyo isina activated COVID-19 yekudzivirira, Sinovac-CoronaVac, yakagadziridzwa neSinovac/China National Pharmaceutical Group.

Ndiani anofanira kutanga kubaiwa?

Nepo COVID-19 yekudzivirira yekudzivirira ishoma, vashandi vehutano vari panjodzi huru yekufumurwa uye vanhu vakuru vanofanirwa kuiswa pamberi pekudzivirira.

Nyika dzinogona kutaura nezveWHO Prioritization RoadmapuyeWHO Values ​​Frameworksegwaro rekuisa pamberi pemapoka anotariswa.

Mushonga haukurudzirwe kune vanhu vari pasi pemakore gumi nemasere, zvichimirira mhedzisiro yekumwe kudzidza muboka rezera iroro.

Vakadzi vane pamuviri vanofanira kubaiwa here?

Iro data riripo pajekiseni reSinovac-CoronaVac (COVID-19) muvakadzi vane pamuviri harina kukwana kuongorora kushanda kwejekiseni kana njodzi dzine chekuita nekudzivirira pakubata pamuviri.Zvakadaro, jekiseni iri ijekiseni risingashandiswe rine adjuvant iro rinowanzoshandiswa mune mamwe majekiseni mazhinji ane nhoroondo yekuchengetedzwa zvakanaka, senge Hepatitis B neTetanus, kusanganisira mumadzimai akazvitakura.Kushanda kweiyo Sinovac-CoronaVac (COVID-19) yekudzivirira muvakadzi vane nhumbu saka inotarisirwa kuenzaniswa neinocherechedzwa muvakadzi vasina nhumbu vezera rakafanana.Zvimwe zvidzidzo zvinotarisirwa kuongorora kuchengeteka uye immunogenicity muvakadzi vane pamuviri.

Munguva iyi, WHO inokurudzira kushandiswa kwejekiseni reSinovac-CoronaVac (COVID-19) muvakadzi vane pamuviri kana mabhenefiti ekudzivirira kumukadzi ane pamuviri achipfuura njodzi dzinogona kuitika.Kubatsira vakadzi vane pamuviri kuita ongororo iyi, vanofanirwa kupihwa ruzivo nezve njodzi yeCOVID-19 pakubata pamuviri;zvingangobatsira zvejekiseni munharaunda yenzvimbo yechirwere chetachiona;uye zvino zvisingakwanisi zvekuchengetedza data muvakadzi vane pamuviri.WHO haikurudzire kuongororwa kwepamuviri kusati kwaitwa.WHO haikurudzire kunonoka kubata pamuviri kana kufunga kubvisa pamuviri nekuda kwejekiseni.

Ndiani mumwe anogona kutora jekiseni?

Vaccination inokurudzirwa kune vanhu vane comorbidities zvakaonekwa sekuwedzera njodzi yeCOVID-19 yakaoma, kusanganisira kufutisa, chirwere chemoyo uye chirwere chekufema.

Iyo yekudzivirira inogona kupihwa kune vanhu vanga vaine COVID-19 munguva yakapfuura.Inowanikwa data inoratidza kuti chiratidzo chekudzorera hachigoneki muvanhu ava kusvika kumwedzi mitanhatu mushure mekutapukirwa kwechisikigo.Nekuda kweizvozvo, vanogona kusarudza kunonoka kubayiwa kusvika pakupera kwenguva ino, kunyanya kana kuwanikwa kwejekiseni kwakadzikira.Muzvimiro umo misiyano yekushushikana nehumbowo hwekupukunyuka kwekudzivirira kwekudzivirira kwemuviri kuri kutenderera kumberi kwejekiseni mushure mekutapukirwa kungave kukurudzirwa.

Kushanda kwejekiseni kunotarisirwa kunge kwakafanana muvakadzi vanoyamwisa sevamwe vanhu vakuru.WHO inokurudzira kushandiswa kweiyo COVID-19 yekudzivirira yeSinovac-CoronaVac mukuyamwisa vakadzi sezvakaita vamwe vanhu vakuru.WHO haikurudzire kurega kuyamwisa mushure mekudzivirira.

Vanhu vanorarama nehuman immunodeficiency virus (HIV) kana vasina immunocompromised vari panjodzi huru yechirwere cheCOVID-19.Vanhu vakadai havana kuverengerwa muzviedzo zvekiriniki zvichizivisa ongororo yeSAGE, asi vakapihwa iyi jekiseni isingadzokorore, vanhu vanorarama neutachiona hweHIV kana vasina kudzivirirwa uye vari chikamu cheboka rinokurudzirwa kubayiwa vanogona kubaiwa.Ruzivo uye kurairirwa, pese pazvinogoneka, zvinofanirwa kupihwa kuzivisa ongororo yenjodzi yemunhu.

Nderipi jekiseni risingakurudzirwe?

Vanhu vane nhoroondo yeanaphylaxis kune chero chikamu chekudzivirira havafaniri kuitora.

Vanhu vane acute PCR-yakasimbiswa COVID-19 havafanirwe kubaiwa nhomba kusvika vapora kubva kuhurwere hwakanyanya uye maitiro ekupedza kuzviparadzanisa asangana.

Ani nani ane tembiricha yemuviri inodarika 38.5°C anofanira kumbomira kubayiwa nhomba kusvikira asisina kupisa.

Ndeipi dosage inokurudzirwa?

SAGE inokurudzira kushandiswa kwejekiseni reSinovac-CoronaVac semadhosi maviri (0.5 ml) akapihwa intramuscularly.WHO inokurudzira nguva yevhiki 2-4 pakati pekutanga uye yechipiri dose.Zvinokurudzirwa kuti vanhu vese vanobaiwa vapihwe mapiritsi maviri.

Kana iyo yechipiri dhizaini ichipihwa isingasviki mavhiki maviri mushure mekutanga, iyo dose haidi kudzokororwa.Kana kupihwa kwepiritsi yepiri kwakanonoka kupfuura mavhiki mana, inofanirwa kupihwa nekukurumidza.

Mushonga uyu unofananidzwa sei nemamwe majekiseni atove kushandiswa?

Hatigone kuenzanisa majekiseni musoro-ne-mumusoro nekuda kwenzira dzakasiyana dzakatorwa mukugadzira zvidzidzo, asi zvakazara, ese ekudzivirira awana WHO Emergency Use Listing anoshanda zvakanyanya mukudzivirira chirwere chakakomba uye kuchipatara nekuda kweCOVID-19. .

Kwakachengeteka here?

SAGE yakanyatso ongorora iyo data pamhando, kuchengetedzeka uye kushanda kwejekiseni uye yakakurudzira kushandiswa kwayo kune vanhu vane makore gumi nemasere uye pamusoro.

Dhata rekuchengetedza parizvino rakaganhurirwa kune vanhu vari pamusoro pemakore makumi matanhatu ezera (nekuda kwenhamba shoma yevatori vechikamu mumakiriniki ekuyedzwa).

Kunyange pasina misiyano yekuchengetedzwa kwemushonga wejekiseni muvakuru vakuru kana uchienzaniswa nemapoka ezera diki unogona kutarisirwa, nyika dziri kufunga nezvekushandisa jekiseni iri muvanhu vakura kupfuura makore makumi matanhatu dzinofanira kuramba dzichiongorora kuchengetedza.

Sechikamu chemaitiro eEUL, Sinovac yakazvipira kuenderera mberi nekuendesa dhata pamusoro pekuchengetedza, kushanda nesimba uye hunhu mukuyedzwa kunoenderera mberi kwekudzivirira uye kuburitswa muhuwandu, kusanganisira muvakuru vakuru.

Mushonga unoshanda zvakadii?

Muyedzo wakakura wechikamu chechitatu muBrazil wakaratidza kuti madosi maviri, akapihwa mukati memazuva gumi nemana, aive nekuita kwe51% kurwisa hutachiona hweSARS-CoV-2, 100% vachipokana neCCIDID-19, uye 100% vachipesana nechipatara kutanga gumi nemana. mazuva mushure mekugamuchira chiyero chechipiri.

Inoshanda here kurwisa zvitsva zvakasiyana zveSARS-CoV-2 hutachiona?

Muchidzidzo chekutarisa, kushanda kunofungidzirwa kweSinovac-CoronaVac muvashandi vehutano muManaus, Brazil, uko P.1 yakaverengera makumi manomwe neshanu muzana eSARS-CoV-2 samples yaive 49.6% kurwisa hutachiona hwechiratidzo (4).Kubudirira kwakaratidzwawo muongororo yekuongorora muSao Paulo pamberi peP1 kutenderera (83% yemasampuli).

Ongororo munzvimbo umo P.2 Variant of Concern yakanga ichitenderera zvakanyanya - zvakare muBrazil - inofungidzirwa kushanda kwejekiseni ye49.6% ichitevera kanenge kamwe kamwe uye yakaratidza 50.7% mavhiki maviri mushure mepiritsi yechipiri.Sezvo data idzva richiwanikwa, WHO inovandudza kurudziro zvinoenderana.

SAGE parizvino inokurudzira kushandisa mushonga uyu, maererano neWHO Prioritization Roadmap.

Inodzivirira utachiona uye kutapuriranwa here?

Parizvino hapana dhata rakakosha riripo rine chekuita nekukanganisa kweCCIDID-19 yekudzivirira Sinovac-CoronaVac pakutapurirana kweSARS-CoV-2, hutachiona hunokonzera chirwere cheCOVID-19.

Zvichakadaro, WHO inoyeuchidza nezve kukosha kwekugara munzira uye kuenderera mberi nekuita hutano hweveruzhinji uye hwemagariro matanho anofanirwa kushandiswa senzira yakazara yekudzivirira hutachiona uye kutapurirana.Matanho aya anosanganisira kupfeka mask, kufamba kure, kugeza maoko, kufema uye kukosora hutsanana, kudzivirira mhomho uye kuona mhepo yakakwana maererano nezano renyika.